Correlation Between G1 Therapeutics and Axsome Therapeutics
Can any of the company-specific risk be diversified away by investing in both G1 Therapeutics and Axsome Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining G1 Therapeutics and Axsome Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between G1 Therapeutics and Axsome Therapeutics, you can compare the effects of market volatilities on G1 Therapeutics and Axsome Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in G1 Therapeutics with a short position of Axsome Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of G1 Therapeutics and Axsome Therapeutics.
Diversification Opportunities for G1 Therapeutics and Axsome Therapeutics
-0.4 | Correlation Coefficient |
Very good diversification
The 3 months correlation between GTHX and Axsome is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding G1 Therapeutics and Axsome Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Axsome Therapeutics and G1 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on G1 Therapeutics are associated (or correlated) with Axsome Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Axsome Therapeutics has no effect on the direction of G1 Therapeutics i.e., G1 Therapeutics and Axsome Therapeutics go up and down completely randomly.
Pair Corralation between G1 Therapeutics and Axsome Therapeutics
Given the investment horizon of 90 days G1 Therapeutics is expected to generate 3.31 times more return on investment than Axsome Therapeutics. However, G1 Therapeutics is 3.31 times more volatile than Axsome Therapeutics. It trades about 0.09 of its potential returns per unit of risk. Axsome Therapeutics is currently generating about 0.03 per unit of risk. If you would invest 343.00 in G1 Therapeutics on September 3, 2024 and sell it today you would earn a total of 372.00 from holding G1 Therapeutics or generate 108.45% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 77.19% |
| Values | Daily Returns |
G1 Therapeutics vs. Axsome Therapeutics
Performance |
| Timeline |
| G1 Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Strong
| Axsome Therapeutics |
G1 Therapeutics and Axsome Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with G1 Therapeutics and Axsome Therapeutics
The main advantage of trading using opposite G1 Therapeutics and Axsome Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if G1 Therapeutics position performs unexpectedly, Axsome Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axsome Therapeutics will offset losses from the drop in Axsome Therapeutics' long position.| G1 Therapeutics vs. Allogene Therapeutics | G1 Therapeutics vs. Heron Therapeuti | G1 Therapeutics vs. Annexon | G1 Therapeutics vs. Sangamo Therapeutics |
| Axsome Therapeutics vs. Incyte | Axsome Therapeutics vs. Sarepta Therapeutics | Axsome Therapeutics vs. ACADIA Pharmaceuticals | Axsome Therapeutics vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |